Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001227790 | SCV001400163 | uncertain significance | Growth hormone insensitivity with immune dysregulation 1, autosomal recessive | 2023-08-04 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt STAT5B protein function. ClinVar contains an entry for this variant (Variation ID: 955195). This variant has not been reported in the literature in individuals affected with STAT5B-related conditions. This variant is present in population databases (rs777627496, gnomAD 0.02%). This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 556 of the STAT5B protein (p.Ser556Thr). |
Fulgent Genetics, |
RCV002480748 | SCV002775876 | uncertain significance | Growth hormone insensitivity with immune dysregulation 1, autosomal recessive; Growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant | 2021-07-14 | criteria provided, single submitter | clinical testing |